Atipay Medical Co., a member of Parmis Medical Holding, proudly participated in the IRAN MED 2025 Exhibition held on 9-12 Oct 2025, showcasing its expanding portfolio of clinically differentiated medical consumables. The company highlighted its focus on high-value product categories including vascular access, urology, anesthesia, wound and ostomy care, and advanced surgical consumables. Representatives from Atipay’s Business Development, RA/QA, and Commercial teams met with local and international partners to explore new collaboration opportunities and introduce the company’s 90–180-day launch model designed to accelerate brand adoption in the Iranian market.

As part of Parmis Medical Holding, Atipay emphasized the group’s nationwide distribution network across 31 provinces, ISO-certified quality systems (ISO 13485 & 9001), and operational support through its regional hubs in Dubai and Istanbul. The company also presented updates on regulatory pathways, MOH dossier alignment, and optional incentive-led localization models. Atipay’s presence at IRAN MED 2025 reinforced its commitment to bringing reliable, innovative medical disposables to healthcare providers across Iran and strengthening long-term partnerships with global manufacturers.